Clinical trials
Sarcopenia clinical trials
Below are recruiting sarcopenia clinical trials, each written for real people, not researchers. We’re tracking 182 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07345832Recruiting
Volunteer-led lifestyle program for older adults with muscle loss
This study tests a volunteer-led program to improve muscle health in older adults with sarcopenia. It uses a mobile app to guide exercise and nutrition, and aims to see if this approach helps people regain strength.
Hong KongAges 60 years+ - NCT07817758Recruiting
Sarcopenia and surgery outcomes in older gastrointestinal cancer patients
This trial looks at whether low muscle mass (sarcopenia) before surgery affects recovery for older adults with gastrointestinal cancer. It may help doctors personalize care and improve outcomes.
Van, VanAges 60 years+ - NCT06475118Recruiting
Blood tests and scans to measure muscle loss in liver cancer
This study looks at whether measuring certain proteins in your blood (myokines) can help detect muscle loss (sarcopenia) in people with liver cancer, and compares these blood tests to special CT scans. If you're newly diagnosed with liver cancer and have a CT scan already, you may be able to join.
ReimsAges 18 years+ - NCT07183774Recruiting
Does muscle loss affect shoulder tear patterns?
This study looks at whether sarcopenia (age-related muscle loss) affects the type of rotator cuff tear you have. You'll get a shoulder MRI to check your rotator cuff and muscle measurements.
Istanbul, ÜsküdarAges 40–75 - NCT07127692Enrolling by invitation
Medicines and muscle loss in older adults with falls
This study looks at whether certain medicines might make muscle loss and falls worse in older adults. If you are 65 or older, have been diagnosed with sarcopenia, and have fallen recently, this trial may help find out if your medications could be improved.
Gillingham, KentAges 65 years+ - NCT07072195RecruitingPhase 2
A study of AMC6156 for people with muscle loss
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
Seongnam-si, Gyeonggi-doAges 65 years+ - NCT06876090Recruiting
Sarcopenia study in women with gestational diabetes
This trial looks at muscle health (sarcopenia) in women who had gestational diabetes during pregnancy. It aims to understand how gestational diabetes might affect muscle mass and function.
ViennaAges 35 years+ - NCT06853275Recruiting
How movement speed affects muscle use in older adults with sarcopenia
This study tests whether giving you feedback on how fast you move during exercises can improve muscle activation and how you feel about your body. It is for older adults with sarcopenia who have not done resistance training recently.
Omaha, NebraskaAges 60–95 - NCT06274268Recruiting
Sarcopenia and cancer treatment side effects study
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
ChambéryAges 18 years+ - NCT05193136Recruiting
Testing sleep and exercise effects on strength and thinking in lung disease
This trial studies whether improving sleep habits can help people with lung conditions like COPD or IPF maintain muscle strength and thinking (cognitive function). It may help by addressing sleep quality and related health factors, but eligibility depends on your current diagnoses and treatments.
Jōyō, KyotoAges 20 years+ - NCT05926713Recruiting
Diet supplement plus exercise for muscle loss with lung disease
This trial studies whether adding a dietary supplement to exercise can improve muscle strength in people with muscle loss (sarcopenia) who also have lung disease such as COPD or ILD. It may help you build strength and function without needing urgent hospital care.
TaichungAges Any age - NCT05502198Recruiting
How muscle loss matters in advanced liver disease
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
EksjöAges 18 years+ - NCT05063955Recruiting
Study muscle changes in people with heart failure
This study looks at the reasons for age-related muscle loss (sarcopenia) in people with heart failure. It may help researchers understand what is causing muscle weakness and how it could be treated in the future.
Aarhus NAges 18–90 - NCT07855419Recruiting
Muscle loss and steroid injections for lumbar spinal stenosis
This study looks at whether the amount of muscle loss (sarcopenia) affects how well steroid injections into the spine work for people with lumbar spinal stenosis, a condition that causes back and leg pain from narrowing of the spinal canal.
Istanbul, IstanbulAges 50–75 - NCT07858864Recruiting
GLP-1 weight loss drugs and muscle health in obesity
This study looks at how GLP-1 receptor agonist drugs (used for weight loss) affect muscle mass and strength in people with obesity who do not have diabetes. It may help understand if these medications impact muscle health.
Istanbul, KucukcekmeceAges 18 years+ - NCT07865676RecruitingPhase 1/Phase 2
Stem cell injection for age-related muscle loss
This trial tests an injection of donor bone marrow stem cells to see if it can improve muscle strength and function in people with age-related muscle loss, called sarcopenia. It may help those who cannot do regular exercise training.
GuangzhouAges 50–85 - NCT06300541Recruiting
Sarcopenia in inflammatory bowel disease flare-ups
This study looks at how common muscle loss (sarcopenia) is in people with inflammatory bowel disease during a flare-up, and what impact it has. By participating, you may help doctors better understand and treat muscle weakness in IBD.
GothenburgAges 18 years+ - NCT06327594Recruiting
Muscle loss check in lung cancer surgery patients
This study looks at muscle loss (sarcopenia) in people with lung cancer who are about to have surgery. It uses a CT or MRI scan to check your muscle health, which may help doctors better plan your care.
Chengdu, SichuanAges 40–100 - NCT06280443Recruiting
Frailty and muscle loss in chronic lung disease
This study looks at people with COPD or ILD who also show signs of frailty. It aims to understand how frailty and muscle loss (sarcopenia) affect their care and use of medical resources over time.
TaichungAges 20 years+ - NCT06380777Recruiting
Digital system for diagnosing and treating sarcopenia
This study is testing a new digital system to help diagnose and manage sarcopenia (age-related muscle loss). It aims to make it easier for doctors to track and treat muscle loss, which can improve your strength and quality of life.
Beijing, Beijing MunicipalityAges 45 years+ - NCT07830472Recruiting
Robot leg training for age-related muscle loss
This study tests whether a leg-training robot can help older adults with sarcopenia—a condition of losing muscle mass and strength as they age—improve their leg strength and function. The robot supports your legs during exercises, which might be safer and more effective than doing them alone.
Taipei, Taipei CityAges 60 years+ - NCT07787312Recruiting
Ultrasound for swallowing and muscle loss in intensive care patients
This study uses ultrasound to check the muscles that help you swallow and move. It aims to see if measuring these muscles can predict swallowing problems and muscle loss after being on a breathing machine.
Madrid, MadridAges 18 years+ - NCT06537115RecruitingPhase 4
Vitamin D, protein, and exercise for muscle loss
This trial tests whether a combination of a vitamin D-like drug (idecalcitol), whey protein powder, and a structured exercise program can help rebuild muscle strength and mass in people with sarcopenia. It lasts about 6 months.
Hangzhou, ZhejiangAges 30 years+ - NCT07764172Recruiting
Sarcopenia in acute ischemic stroke
This study looks at muscle loss (sarcopenia) in people who have had an acute ischemic stroke. It aims to understand how muscle wasting affects recovery, which may help improve care for stroke patients.
MoscowAges 50 years+
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Sarcopenia trials by city
Studies with a site in or near these metro areas.
Sarcopenia trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for sarcopenia?
- Yes. Clin2 currently lists 182 recruiting sarcopenia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a sarcopenia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a sarcopenia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.